0 CHECKOUT

Research Update: Lend Lease Corp. 'BBB-/A-3' Ratings Affirmed; Outlook Stable Following Equity-Raising Plan Feb 10

  • ID: 2153410
  • February 2010
  • Standard & Poors

FEATURED COMPANIES

  • Lend Lease Corp. Ltd.
  • Lend Lease Finance Ltd.
  • MORE

Abstract
Lend Lease announced plans for a fully underwritten A$806 million equity raising. We have affirmed our 'BBB-/A-3' ratings on Lend Lease. We have removed the rating from CreditWatch with negative implications, and assigned a stable outlook. On Feb. 25, 2010, Standard & Poor's Ratings Services affirmed its 'BBB-' long-term and 'A-3' short-term credit ratings on Lend Lease Corp. Ltd. (LLC) and LLC's related debt issues and programs following the Australian-based property group's proposed fully underwritten A$806 million equity raising. At the same time, the ratings were removed from CreditWatch with negative implications, where they were placed on Dec. 16, 2009. The outlook on the long-term rating is stable. LLC was placed on CreditWatch after the group secured new business transactions...

Companies mentioned in this report are:
- Lend Lease Corp. Ltd.
- Lend Lease Finance Ltd.
- Lend Lease (US) Capital Inc.
- Lend Lease Europe Finance PLC

Action: Affirmed
Action: Outlook: Stable
Action: Removed From CreditWatch

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, READ MORE >

Note: Product cover images may vary from those shown

- Lend Lease Corp. Ltd.
- Lend Lease Finance Ltd.
- Lend Lease (US) Capital Inc.
- Lend Lease Europe Finance PLC

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.